Can Non-Diabetics Use Metformin for Weight Loss?


Should you try metformin for weight loss? Learn how it works, what the research says, and whether it might be right for you.
- A licensed provider may prescribe metformin for weight loss off-label, but the medication is only FDA-approved for type 2 diabetes.
- Research suggests metformin may be associated with modest weight loss, particularly in people with insulin resistance or prediabetes.
- Metformin is not a weight-loss drug; results vary, and it works best when used alongside healthy lifestyle habits, such as balanced nutrition, regular exercise, and effective stress management techniques.
- Gastrointestinal side effects are the most commonly reported and may include symptoms such as nausea, diarrhea, bloating, or abdominal discomfort, particularly when starting treatment or increasing the dose.
This article is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any new medication or making changes to your health routine.

What is Metformin?
Metformin has been around for decades. It was approved by the FDA in 1994 to help manage type 2 diabetes, and it remains one of the most commonly prescribed drugs for that purpose today.
As part of a class of drugs called biguanides, metformin primarily reduces the amount of glucose (sugar) your liver produces and helps your body respond more effectively to insulin.
While metformin is designed for blood sugar management, some healthcare providers prescribe it off-label for other uses. As such, you might wonder whether metformin works for weight loss and whether you should bring it up with a licensed provider.
{{primary-cta}}
How Does Metformin Work?
In short, metformin works by altering how your body processes glucose and responds to insulin. Primarily, it reduces the amount of sugar your liver releases into your bloodstream. Your liver naturally produces glucose, but in people with insulin resistance, it can produce too much. And metformin can help slow this down.
This medication also improves insulin sensitivity. This means your cells become better at using the insulin your body already produces. In turn, this may help keep your blood sugar levels more stable, which can be very beneficial for those with type 2 diabetes.
Additionally, metformin may reduce the amount of glucose your intestines absorb from the food you eat, which may further contribute to lower overall post-meal blood sugar.
At the same time, metformin is not approved as a weight-loss medication and is not designed to directly target body fat or suppress appetite.
However, some individuals report changes in appetite while taking metformin. These effects are not fully understood but may be related to metformin’s influence on glucose metabolism, insulin sensitivity, and gut-related pathways involved in energy regulation. In individuals with insulin resistance, improved insulin function may be associated with changes in weight over time.
When weight changes do happen, they are typically modest, variable between individuals, and never guaranteed.
What Does the Research Say About Metformin for Weight Loss?
Most of the research on metformin and weight loss comes from studies involving people with prediabetes, insulin resistance, or other metabolic conditions. In other words, the studies on metformin for weight loss in the general population are limited.
With that said, here are some of the key research findings:
- The Diabetes Prevention Program (DPP): This landmark trial followed over 3,200 adults with prediabetes for an average of 2.8 years. Participants assigned to metformin (850 mg twice daily) lost an average of 2.1 kg (4.6 lbs), compared with 0.1 kg in the placebo group. About 30% lost more than 5% of their body weight in the first year.
- DPP Outcomes Study (DPPOS) - 15-Year Follow-Up: People who lost at least 5% of their weight with metformin maintained an average weight loss of about 6.2% over long-term follow-up (years 6-15).
- Real-World Outpatient Study (Non-Diabetic Patients): A 2013 study followed 154 obese patients without diabetes taking metformin for six months. The average weight loss was 5.8 kg (about 12.8 lbs). However, the results were more pronounced in those with higher insulin resistance.
- 2024 Meta-Analysis: A recent systematic review of randomized controlled trials suggested that metformin is associated with a modest weight reduction in non-diabetic adults with overweight or obesity; though researchers noted that results varied, results aren’t guaranteed, and more high-quality studies are needed.
Overall, research suggests metformin may support modest, gradual results, particularly in people with insulin resistance or prediabetes. At the same time, individual responses vary, and it tends to work best when combined with lifestyle changes.
Who Might Be a Candidate for Metformin?
Since it’s not FDA-approved for weight loss, metformin may be prescribed off-label at a licensed healthcare provider’s discretion.
You might be a candidate for metformin if you:
- Have prediabetes.
- Have insulin resistance.
- Have polycystic ovary syndrome (PCOS).
- Haven’t seen results with lifestyle changes alone.
Metformin may not be appropriate if you have certain kidney or liver conditions, a history of lactic acidosis, or other health factors your provider would need to evaluate. A qualified healthcare professional can help determine whether it makes sense for your specific health circumstances.
{{primary-cta}}
Metformin Side Effects
The most commonly reported side effects include:
- Nausea
- Diarrhea
- Stomach upset or cramping
- Bloating or gas
- Reduced appetite
Often, these symptoms improve within a few weeks as your body adjusts. Many providers also recommend the extended-release (ER) formulation, which tends to be gentler on the stomach. If you have any concerns about the side effects above, it’s best to discuss them with your healthcare provider.
It’s also worth noting that long-term metformin use has been associated with reduced vitamin B12 levels in some individuals, which, if left unaddressed, may contribute to symptoms such as fatigue, weakness, or numbness.
In rare cases, metformin has been associated with lactic acidosis, a serious condition that can occur if the medication accumulates in the body. This risk is higher in people with significant kidney impairment or other contraindications, which is why metformin is not recommended for everyone and should be prescribed with appropriate screening and monitoring.
If you experience severe or persistent side effects, it’s important to let your healthcare provider know so they can adjust your treatment based on your specific health circumstances.
Metformin Alternatives
Metformin is not FDA-approved for weight loss, and when weight management is the primary concern, a licensed healthcare provider may consider other options, particularly for individuals without diabetes or insulin resistance.
In recent years, GLP-1 receptor agonists have been approved by the FDA for chronic weight management in certain adults with obesity or overweight and qualifying health conditions. These include medications such as Wegovy®, which is FDA-approved for chronic weight management.
Ultimately, a licensed healthcare professional can help determine which might be appropriate for you. At the same time, lifestyle interventions are key to starting any weight-loss journey. This includes making appropriate changes in nutrition, exercise, sleep, or stress management.
Final Thoughts
Metformin has been prescribed for decades for approved indications, but it’s not FDA-approved for weight loss. However, some studies suggest it may be associated with modest weight changes in certain populations, such as individuals with insulin resistance, prediabetes, or polycystic ovary syndrome (PCOS). Yet, responses vary, and potential benefits depend on individual health factors and clinical context.
Thus, if you’re considering metformin for weight loss, it’s important to discuss your options with your physician and determine if you’re a candidate. They can evaluate your health history, discuss your goals, and help you decide whether metformin or another option makes sense for you.

Blog Components

The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Eden is not a medical provider. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by state-licensed pharmacies. Please consult a licensed healthcare provider before making any medical decisions.
Frequently asked questions
It may. Research shows that metformin can support modest weight loss in non-diabetic individuals, particularly those with insulin resistance or prediabetes; though results vary, and it’s not FDA-approved for this use.
There is no standard dose approved for weight loss. In research settings, metformin has been studied at total daily doses of around 1,500 mg to 2,000 mg per day, but dosing should always be determined by a licensed healthcare provider based on your individual health factors.
No, metformin is FDA-approved for type 2 diabetes, but healthcare providers may prescribe it off-label for weight management in certain individuals.
Gastrointestinal issues, such as nausea, diarrhea, and stomach upset, are the most common. These often improve over time or with an extended-release formulation.
Apolzan, J. W., Venditti, E. M., Edelstein, S. L., Knowler, W. C., Dabelea, D., Boyko, E. J., Pi-Sunyer, X., Kalyani, R. R., Franks, P. W., Srikanthan, P., Gadde, K. M., & Diabetes Prevention Program Research Group (2019). Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study. Annals of internal medicine, 170(10), 682–690. https://doi.org/10.7326/M18-1605
Corcoran, C., & Jacobs, T. F. (2023, August 17). Metformin. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK518983/
Haber, R., Zarzour, F., Ghezzawi, M., Saadeh, N., Bacha, D. S., Al Jebbawi, L., Chakhtoura, M., & Mantzoros, C. S. (2024). The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta-analysis of randomized controlled trials. Diabetes, obesity & metabolism, 26(5), 1850–1867. https://doi.org/10.1111/dom.15501
Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A., Nathan, D. M., & Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England journal of medicine, 346(6), 393–403. https://doi.org/10.1056/NEJMoa012512
Sayedali, E., Yalin, A. E., & Yalin, S. (2023). Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes. World journal of diabetes, 14(5), 585–593. https://doi.org/10.4239/wjd.v14.i5.585
Seifarth, C., Schehler, B., & Schneider, H. J. (2013). Effectiveness of metformin on weight loss in non-diabetic individuals with obesity. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 121(1), 27–31. https://doi.org/10.1055/s-0032-1327734
WEGOVY. (2021). WEGOVY (semaglutide) injection, for subcutaneous use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
Thank you!
We'll be in touch.
Thank you!

















.webp)
.webp)
.webp)
.webp)